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doi:10.1016/j.kjms.2010.11.008Abstract Kidney stones are a potential risk factor for chronic kidney disease. The impact of
different urinary stone components on renal function is unknown. In this study, we retrospec-
tively reviewed 1,918 medical records of patients with urolithiasis. The renal function was
evaluated as estimated glomerular filtration rate. All the stones were analyzed by Fourier
transform infrared spectroscopy. The patients were divided into five groups according to the
stone components. Statistical analysis was performed with analysis of variance. All the
patients with stones had Stage 2e3 chronic kidney disease. The patients with uric acid and
struvite stones had significantly lower estimated glomerular filtration rate compared with
those having other stone components (p< 0.01). Furthermore, the patients with calcium-
containing stones (calcium oxalate and calcium phosphate) had significantly better renal
function than those with non-calcium-containing stones (struvite and uric acid, p< 0.01).
Patients with urolithiasis had decreased renal function, and the impact of renal function varied
depending on the stone components. We conclude that stone analysis is important in predict-
ing the change in renal function in patients with urolithiasis. Moreover, the patients with non-
calcium-containing stones, such as struvite and uric acid stones, should be carefully evaluated
and treated to preserve their renal function.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.of Urology, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung 807, Taiwan.
(H.-S. Wang).
vier Taiwan LLC. All rights reserved.
Table 1 Clinical characteristics of patientswith urolithiasis
Characteristics n (%)
Gender
Male 1,384 (72)
Female 534 (38)
Male:female ratio 2.59:1
Age (yr), mean (standard deviation) 54.0  13.8
Stone components
Calcium-containing stones 1,736 (90.5)
Calcium phosphate 204 (10.6)
Calcium oxalate 579 (30.2)
Calcium oxalateecalcium phosphate 953 (49.7)
Non-calcium-containing stones 182 (9.5)
Struvite 21 (1.1)
Uric acid 161 (8.4)
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Kidney stones are a common disease in the general pop-
ulation, its prevalence being 5e10%, with a male predomi-
nance and anestimated recurrence rate of 50%. Furthermore,
the prevalence of kidney stones has been increasing in the
recent decades [1e3]. Previous studies have considered
kidney stones as a potential risk factor for chronic kidney
disease (CKD), associated with significant morbidity,
mortality, and heath care cost [4e6]. To date, themechanism
accounting for this association is not completely understood.
There are several components of urinary stones, such as
calcium oxalate, calcium phosphate, uric acid, and struvite
[7]. The relationships between stone components and the
changeof renal functionareunclear. Thepurposeof this study
was, therefore, to analyze the impact of urinary stones on
renal function, according to the different stone components.
We observed an association between renal stone components
and estimated glomerular filtration rate (eGFR) of the
stone formers.Table 2 The estimated glomerular filtration rate in rela-
tion to stone componentsMaterials and methods
We reviewed the medical records of patients with upper
urinary tract stones, hospitalized from February 2004 to
March 2009 in the Department of Urology, Kaohsiung Medical
University Hospital. All patients had radiological evidence of
urinary stones;most of the stones had passed spontaneously,
whereas some of them were collected by surgical proce-
dures. The exclusion criteria were as follows: preexisting
chronic renal failure, chronic ureteral obstruction in both
kidneys or in a solitary kidney, congenital renal anomalies,
and autosomal dominant polycystic kidney disease.
Clinical data, such as gender, age, and stone components,
were collected. Renal function was evaluated with eGFR
using the modification of diet in renal disease formula [8,9].
The stone components were analyzed by Fourier transform
infrared spectroscopy [10]. All patients were classified into
five groups according to the stone components, namely,
calcium phosphate, calcium oxalate, calcium oxalate mixed
with calcium phosphate, struvite, and uric acid stones.
Statistical analysis was performed with Student t test,
analysis of variance, and Tukey’s post hoc test. A p value less
than 0.05 was defined as statistically significant.Stone components MDRD eGFR
(mL/min/1.73 m2)
Calcium phosphate 67.0 23.7
Calcium oxalate 70.3 21.5
Calcium oxalate/calcium
phosphate
73.4 22.6
Struvite 54.9 18.6a
Uric acid 54.1 17.1a
Calcium-containing stones 71.7 22.5b
Non-calcium-containing stones 54.6 17.6b
a A p value <0.05 as determined by analysis of variance and
Tukey’s post hoc test.
b A p value <0.05 as determined by Student t test.
Data are presented as mean standard deviation.
eGFRZ estimated glomerular filtration rate; MDRDZmodifi-
cation of diet in renal disease.Results
This study included 1,918 patients with upper urinary tract
stones. The patients’ average age was 54.0  13.8 years,
and the male:female ratio was 2.59:1. With regard to the
prevalence of stone composition, there were 1,736 (90.5%)
calcium-containing stones, including 953 (49.7%) calcium
oxalate mixed with calcium phosphate stones; 579 (30.2%)
calcium oxalate stones; 204 (10.6%) calcium phosphate
stones; and 182 (9.5%) non-calcium-containing stones, of
which 21 (1.1%) were struvite stones and 161 (8.4%) were
uric acid stones (Table 1). The most common chemical
component of stones was calcium oxalate mixed with
calcium phosphate, followed by calcium oxalate, calcium
phosphate, uric acid, and struvite. When analyzing therenal function in relation to stone components, patients
with calcium oxalate mixed with calcium phosphate stones
showed the highest eGFR: 73.4 22.6 mL/min/1.73 m2; in
contrast, patients with uric acid stones had the lowest
eGFR: 54.1 17.1 mL/min/1.73 m2. The eGFR values were
67.0 23.7 mL/min/1.73 m2, 70.3 21.5 mL/min/1.73 m2,
and 54.9 18.6 mL/min/1.73 m2 in patients with calcium
phosphate, calcium oxalate, and struvite stones, respec-
tively. Patients with calcium-containing stones (calcium
phosphate and calcium oxalate) had significantly better
renal function compared with those with non-calcium-
containing stones (struvite and uric acid, p< 0.01)
(Table 2).
The renal function was significantly different among the
five groups of patients with varying stone compositions
(p< 0.01, analysis-of-variance test). Tukey’s post hoc test
revealed that the eGFR of struvite stone formers was
significantly different from those of calcium oxalate,
calcium phosphate, and mixed calcium oxalate/calcium
phosphate stone formers. The eGFR of uric acid stone
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oxalate, calcium phosphate, and mixed calcium oxalate/
calcium phosphate stone formers. The difference between
struvite and uric acid stone formers was not statistically
significant.Discussion
The impact of CKD on public health is well documented.
CKD patients have an increased risk of morbidity and
mortality compared with the general population. Hence,
the identification of possible risk factors associated with
the development of renal disease has become an important
focus area for researchers [11,12]. Because the incidence
of CKD has been increasing worldwide over the last
decades, the frequency of renal stone disease has also
increased [1]. Although much is known about the treatment
of stone disease, the clinical consequences of stone disease
remain relatively unidentified. In particular, little is known
about the effect of stone disease on renal function except
for renal obstruction [13].
Some studies have shown an association between kidney
stone disease and chronic kidney function impairment.
However, some stone formers may develop chronic kidney
function impairment and some may not. The possible cau-
ses and risk factors for renal function damage in patients
with urinary stones include anatomical abnormality (e.g.,
obstructive nephropathy); infection and inflammation with
parenchymal scar formation; underlying metabolic disor-
ders (e.g., chronic urate nephropathy); environmental
factors; repeated interventions; dietary factors; and
molecular or genetic factors [14e16]. Hypertension and
diabetes, the well-established risk factors, were signifi-
cantly associated with chronic kidney functional impair-
ment in general population as well as in stone formers
[17,18]. According to the National Kidney Foundation
Kidney Disease Outcomes Quality Initiative guidelines for
CKD, all the stone groups analyzed in this study fall into CKD
Stage 2e3. The eGFR was significantly lower in uric acid and
struvite stone patients than in patients with other stone
types (p< 0.01).
In terms of the underlying causes of renal function
impairment, recent studies have indicated that the formation
of stones is associated with the deposition of particles in the
basement membranes of the thin loops of Henle and in the
deepmedullary interstitium[19]. Suchadepositionmaycause
interstitial inflammation and facilitate the development of
fibrosis, which results in tubular cell injury and damage of
renal function. Furthermore, stone passage itself causes
transient obstruction, and obstruction is a well-established
risk factor for renal damage. Stone treatments, such as
extracorporeal shock-wave lithotripsy and percutaneous
nephrolithotripsy, have been shown to cause renal injury in
experimental animal and human studies andmay result in the
loss of renal function. However, most clinical studies have
suggested that the initial decline in eGFR, secondary to
treatment-inducedkidney injury, improvedover time[20,21].
Currently, there is no evidence suggesting an association
among the number of stones, the procedures used for treat-
ment, and the risk of functional impairment in CKD. Obesity,
one of the risk factors for urolithiasis, is another risk factor forrenal damage. Gillen et al. [4] reported that obese patients
with stone disease had a higher frequency of decreased renal
function than those without the disease.
With regard to the effect of stone components on renal
function, few studies have compared the effects of
different stone components on renal function. The pres-
ence of struvite stones in some patients may cause the
development of renal failure because of recurrent urinary
infection [22,23].
This study indicated the presence of a lower eGFR in
patients with non-calcium stone components than in those
with calcium stone components. This finding suggests that
the stone component is another risk factor for the
progression of functional impairment in CKD. Traditional
risk factors for stone formers included hypertension, dia-
betes, obstruction, and recurrent urinary tract infection.
Two of the most common components of non-calcium
stones were uric acid and struvite. Uric acid stone formers
are commonly associated with diabetes and gout, diseases
that are known to result in renal function impairment
[22,24,25]. Struvite stones are associated with chronic
recurrent urinary tract infection because they grow rapidly
to occupy the entire renal collecting system, resulting in
the loss of renal function [22].
Hypertension, diabetes, aging, chronic urinary tract
infection, and nephrotoxic drugmedication are all important
risk factors for CKD. Besides these, we found that urolith-
iasis, especially in non-calcium urinary stone disease, is also
a risk factor for CKD. In our study, because the sample size
was large, we assumed that the percentage of patients with
hypertension and diabeteswas similar among different stone
component groups. We analyzed the renal function of
patients with urolithiasis on the basis of different stone
components rather than different associated diseases, such
as urinary tract infection, diabetes, hypertension, or aging.
The patients with different stone components may have
various comorbidity rates. In fact, the patients with struvite
stones may develop chronic urinary tract infection, whereas
patients with uric acid stones have a higher probability to
develop diabetes, which may result in chronic renal disease.
Aging is also an important risk factor for CKD. In this study,we
found that patients with non-calcium stones had a worse
renal function as compared with those with calcium-con-
taining stones; this is a very important finding that should be
noted by both physicians and patients, including young
subjects, to maintain renal function.
Our study does have some limitations. In our retrospec-
tive analysis, we did not consider the methods used for
treatment, the association of stone disease duration with
renal function, and the patients’ body mass index. Further
work in different patients is needed to validate our finding
and to determine the possible mechanisms underlying
impaired kidney function.
Our results indicate that nephrolithiasis can be regarded
not only as a stone disease, but also as a kidney function-
impairing disease. Traditional risk factors for CKD include
obstruction, diabetes, hypertension, and urinary tract
infection. Our study showed that stone components were
associated with an impaired renal function. In fact, renal
function in non-calcium-containing stone patients deterio-
rated significantly as compared with those with calcium-
containing stones. Hence, stone analysis is important in
Renal function in patients with urolithiasis 267predicting the change of renal function in patients with
urolithiasis. Patients with non-calcium stones, such as
struvite and uric acid stones, should be carefully evaluated
and treated to preserve the renal function.
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